Literature DB >> 28097472

Proceedings of the third international molecular pathological epidemiology (MPE) meeting.

Peter T Campbell1, Timothy R Rebbeck2,3, Reiko Nishihara3,4, Andrew H Beck5,6, Colin B Begg7, Alexei A Bogdanov8, Yin Cao4,9,10, Helen G Coleman11, Gordon J Freeman3, Yujing J Heng5,6, Curtis Huttenhower12,13, Rafael A Irizarry12,14, N Sertac Kip15, Franziska Michor12,14, Daniel Nevo2,12, Ulrike Peters16,17, Amanda I Phipps16,17, Elizabeth M Poole2,18, Zhi Rong Qian3, John Quackenbush12,14, Harlan Robins16, Peter K Rogan19, Martha L Slattery20, Stephanie A Smith-Warner2,4, Mingyang Song4,9, Tyler J VanderWeele2, Daniel Xia21, Emily C Zabor7, Xuehong Zhang18, Molin Wang2, Shuji Ogino22,23,24,25.   

Abstract

Molecular pathological epidemiology (MPE) is a transdisciplinary and relatively new scientific discipline that integrates theory, methods, and resources from epidemiology, pathology, biostatistics, bioinformatics, and computational biology. The underlying objective of MPE research is to better understand the etiology and progression of complex and heterogeneous human diseases with the goal of informing prevention and treatment efforts in population health and clinical medicine. Although MPE research has been commonly applied to investigating breast, lung, and colorectal cancers, its methodology can be used to study most diseases. Recent successes in MPE studies include: (1) the development of new statistical methods to address etiologic heterogeneity; (2) the enhancement of causal inference; (3) the identification of previously unknown exposure-subtype disease associations; and (4) better understanding of the role of lifestyle/behavioral factors on modifying prognosis according to disease subtype. Central challenges to MPE include the relative lack of transdisciplinary experts, educational programs, and forums to discuss issues related to the advancement of the field. To address these challenges, highlight recent successes in the field, and identify new opportunities, a series of MPE meetings have been held at the Dana-Farber Cancer Institute in Boston, MA. Herein, we share the proceedings of the Third International MPE Meeting, held in May 2016 and attended by 150 scientists from 17 countries. Special topics included integration of MPE with immunology and health disparity research. This meeting series will continue to provide an impetus to foster further transdisciplinary integration of divergent scientific fields.

Entities:  

Keywords:  Meeting report; Molecular pathological epidemiology; Proceedings

Mesh:

Year:  2017        PMID: 28097472      PMCID: PMC5303153          DOI: 10.1007/s10552-016-0845-z

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  68 in total

Review 1.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

2.  Sufficient cause interactions and statistical interactions.

Authors:  Tyler J VanderWeele
Journal:  Epidemiology       Date:  2009-01       Impact factor: 4.822

3.  Sufficient cause interactions for categorical and ordinal exposures with three levels.

Authors:  Tyler J Vanderweele
Journal:  Biometrika       Date:  2010-06-01       Impact factor: 2.445

4.  RNF43 is frequently mutated in colorectal and endometrial cancers.

Authors:  Marios Giannakis; Eran Hodis; Xinmeng Jasmine Mu; Mai Yamauchi; Joseph Rosenbluh; Kristian Cibulskis; Gordon Saksena; Michael S Lawrence; Zhi Rong Qian; Reiko Nishihara; Eliezer M Van Allen; William C Hahn; Stacey B Gabriel; Eric S Lander; Gad Getz; Shuji Ogino; Charles S Fuchs; Levi A Garraway
Journal:  Nat Genet       Date:  2014-10-26       Impact factor: 38.330

5.  Genetic and phenotypic diversity in breast tumor metastases.

Authors:  Vanessa Almendro; Hee Jung Kim; Yu-Kang Cheng; Mithat Gönen; Shalev Itzkovitz; Pedram Argani; Alexander van Oudenaarden; Saraswati Sukumar; Franziska Michor; Kornelia Polyak
Journal:  Cancer Res       Date:  2014-01-21       Impact factor: 12.701

6.  Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.

Authors:  Mingyang Song; Reiko Nishihara; Molin Wang; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci; Kana Wu; Shuji Ogino; Zhi Rong Qian; Kentaro Inamura; Xuehong Zhang; Kimmie Ng; Sun A Kim; Kosuke Mima; Yasutaka Sukawa; Katsuhiko Nosho
Journal:  Gut       Date:  2015-01-15       Impact factor: 23.059

7.  Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.

Authors:  Polly A Newcomb; John Baron; Michelle Cotterchio; Steve Gallinger; John Grove; Robert Haile; David Hall; John L Hopper; Jeremy Jass; Loïc Le Marchand; Paul Limburg; Noralane Lindor; John D Potter; Allyson S Templeton; Steve Thibodeau; Daniela Seminara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11-02       Impact factor: 4.254

8.  Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.

Authors:  Yohei Masugi; Reiko Nishihara; Juhong Yang; Kosuke Mima; Annacarolina da Silva; Yan Shi; Kentaro Inamura; Yin Cao; Mingyang Song; Jonathan A Nowak; Xiaoyun Liao; Katsuhiko Nosho; Andrew T Chan; Marios Giannakis; Adam J Bass; F Stephen Hodi; Gordon J Freeman; Scott Rodig; Charles S Fuchs; Zhi Rong Qian; Shuji Ogino
Journal:  Gut       Date:  2016-05-05       Impact factor: 23.059

Review 9.  Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms.

Authors:  Whay Kuang Chia; Raghib Ali; Han Chong Toh
Journal:  Nat Rev Clin Oncol       Date:  2012-08-21       Impact factor: 66.675

Review 10.  Colorectal cancer.

Authors:  Ernst J Kuipers; William M Grady; David Lieberman; Thomas Seufferlein; Joseph J Sung; Petra G Boelens; Cornelis J H van de Velde; Toshiaki Watanabe
Journal:  Nat Rev Dis Primers       Date:  2015-11-05       Impact factor: 52.329

View more
  12 in total

1.  Shuji Ogino: a critical mass of pathological epidemiologists is needed for transdisciplinary studies.

Authors:  Brad Li
Journal:  Transl Gastroenterol Hepatol       Date:  2018-12-04

Review 2.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

Review 3.  Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.

Authors:  Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Amanda I Phipps; Ulrike Peters; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Marios Giannakis; Wendy S Garrett; Mingyang Song
Journal:  Gut       Date:  2018-02-06       Impact factor: 23.059

Review 4.  Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology.

Authors:  Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Danny A Milner; Reiko Nishihara
Journal:  Annu Rev Pathol       Date:  2018-08-20       Impact factor: 23.472

5.  Utility of inverse probability weighting in molecular pathological epidemiology.

Authors:  Li Liu; Daniel Nevo; Reiko Nishihara; Yin Cao; Mingyang Song; Tyler S Twombly; Andrew T Chan; Edward L Giovannucci; Tyler J VanderWeele; Molin Wang; Shuji Ogino
Journal:  Eur J Epidemiol       Date:  2017-12-20       Impact factor: 8.082

6.  Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting.

Authors:  Peter T Campbell; Christine B Ambrosone; Timothy R Rebbeck; Shuji Ogino; Reiko Nishihara; Hugo J W L Aerts; Melissa Bondy; Nilanjan Chatterjee; Montserrat Garcia-Closas; Marios Giannakis; Jeffrey A Golden; Yujing J Heng; N Sertac Kip; Jill Koshiol; X Shirley Liu; Camila M Lopes-Ramos; Lorelei A Mucci; Jonathan A Nowak; Amanda I Phipps; John Quackenbush; Robert E Schoen; Lynette M Sholl; Rulla M Tamimi; Molin Wang; Matty P Weijenberg; Catherine J Wu; Kana Wu; Song Yao; Kun-Hsing Yu; Xuehong Zhang
Journal:  Cancer Causes Control       Date:  2019-05-08       Impact factor: 2.506

7.  Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting.

Authors:  Song Yao; Peter T Campbell; Tomotaka Ugai; Gretchen Gierach; Montserrat Garcia-Closas; Timothy R Rebbeck; Christine B Ambrosone; Shuji Ogino; Mustapha Abubakar; Viktor Adalsteinsson; Jonas Almeida; Paul Brennan; Stephen Chanock; Todd Golub; Samir Hanash; Curtis Harris; Cassandra A Hathaway; Karl Kelsey; Maria Teresa Landi; Faisal Mahmood; Christina Newton; John Quackenbush; Scott Rodig; Nikolaus Schultz; Guillermo Tearney; Shelley S Tworoger; Molin Wang; Xuehong Zhang
Journal:  Cancer Causes Control       Date:  2022-06-27       Impact factor: 2.532

8.  Revisiting social MPE: an integration of molecular pathological epidemiology and social science in the new era of precision medicine.

Authors:  Jin Dai; Akihiro Nishi; Nathan Tran; Yasumasa Yamamoto; George Dewey; Tomotaka Ugai; Shuji Ogino
Journal:  Expert Rev Mol Diagn       Date:  2021-07-26       Impact factor: 5.670

9.  Harmonisation of biobanking standards in endometrial cancer research.

Authors:  M Adishesh; A Fyson; S B DeCruze; J Kirwan; H M J Werner; D K Hapangama
Journal:  Br J Cancer       Date:  2017-06-29       Impact factor: 7.640

Review 10.  Lifestyle, Diet, and Colorectal Cancer Risk According to (Epi)genetic Instability: Current Evidence and Future Directions of Molecular Pathological Epidemiology.

Authors:  Laura A E Hughes; Colinda C J M Simons; Piet A van den Brandt; Manon van Engeland; Matty P Weijenberg
Journal:  Curr Colorectal Cancer Rep       Date:  2017-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.